Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Celiac Disease
Sort By
Newest First
Sign in
1 / 1
1 / 1
IND Approval
ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten
Precigen ActoBio
PR-M09-19-NI-006
Sep 04, 2019
Celiac Disease
Amgen and Provention Bio Announce Co-Development Collaboration In Celiac Disease
Amgen
PR-M11-18-NI-018
Nov 06, 2018
